RespireLYFTMLive Your Fullest

For your buying team

Move from product interestto a launch plan.

See what participants get, how the first group starts and what your buying team needs to review privacy, delivery and support.

Participant experience

Cough and inhaler use captured for the participant, watch measurements, connected peak flow and local weather, pollen and air quality—one platform. A respiratory food rating, personal patterns and one small step at a time. Participants start on a phone; a compatible smartwatch adds inhaler logging and technique coaching. No smart inhaler or clip-on sensor to buy, ship or recover.

Explore the product

Published privacy policy

Read the current policy for data categories, purposes, sharing, retention and individual choices. Deployment-specific data flows and contracts are reviewed for the proposed service.

Read the privacy policy

Evidence and intended use

Respire LYF supports everyday respiratory self-management and care conversations. Explore the published technical research and the care and FDA policy explanation for your review. Respire LYF operates under FDA’s general-wellness policy: it supports everyday self-management alongside usual care and is not an FDA-cleared device. It does not diagnose, predict attacks or change medicines.

Explore the evidence

Start your internal review

A brief your buying team can use.

Share the proposed population, device scope, fees, responsibilities and readout with your benefits, clinical and procurement colleagues. Bring your security questionnaire to the same scoping conversation so deployment requirements can be resolved in parallel.

AI4LYF’s published privacy policy describes encrypted connections, role-based access, infrastructure monitoring and incident handling. Hosting, subprocessors, retention and contractual evidence for your proposed deployment belong in the deployment review.

Five decisions before a deployment.

  1. 01 · People and permissions

    Define the eligible adult population, invitations, voluntary participation and the permissions needed for each enabled feature.

  2. 02 · Who sees what

    Employer programs receive aggregate reporting only, never employees’ personal health records. Practice, health-plan and care-management programs choose the staff route before launch—shared report, export or staff access—with roles and permissions written into the agreement.

  3. 03 · Data and infrastructure

    Review hosting, subprocessors, access controls, retention, deletion and incident handling for the actual deployment. Identify which records stay in the app and which, if any, need to move.

  4. 04 · Contract and responsibilities

    Define the service, data roles, support and any required data-protection or business-associate agreement. Resolve requirements before participant data is transferred.

  5. 05 · A decision-ready readout

    Set the activation definition, reporting denominators, privacy safeguards and review date before launch. Clinical or claims-savings evaluation needs its own agreed method and scope.

Bring the requirements. Leave with a defined next step.

Tell us your population, data requirements, decision owner and launch window.